Last reviewed · How we verify

Azaribin (AZARIBINE)

FDA-approved withdrawn Small molecule Quality 5/100

At a glance

Generic nameAZARIBINE
Drug classazaribine
TargetOrotidine 5'-phosphate decarboxylase
ModalitySmall molecule
Therapeutic areaOncology
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: